Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Yeast-based immunotherapy against Clostridium difficile infection

Yeast-based immunotherapy against Clostridium difficile infection

US Patent 12384833 · Granted Aug 12, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Live salmonella typhi vectors engineered to express heterologous outer membrane 2025
Pharmaceutical formulation2025
Chimeric antigen receptors (CARs), compositions and methods thereof2025
Pharmaceutical formulation2025
Protein inhibitors of clostridium difficile toxin b2024
Methods, compositions and kits for treating a subject using a recombinant hetero2024
Humanized tetra-specific octavalent antibody against clostridium difficile toxin2024
Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositi2024
Chimeric antigen receptors (CARs), compositions and methods thereof2023
Live Salmonella typhi vectors engineered to express heterologous outer membrane 2023
Chimeric antigen receptors (CARs), compositions and methods of use thereof2023
Yeast-based immunotherapy against clostridium difficile infection2022